These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31693811)

  • 21. Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease.
    Chun HS
    Gut Liver; 2023 Jul; 17(4):485-486. PubMed ID: 37449428
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity.
    Georgoulis M; Fragopoulou E; Kontogianni MD; Margariti A; Boulamatsi O; Detopoulou P; Tiniakos D; Zafiropoulou R; Papatheodoridis G
    Nutr Res; 2015 Jan; 35(1):41-8. PubMed ID: 25530013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation?
    Naderian M; Ebrahimi H; Sohrabpour AA
    Hepatology; 2016 Oct; 64(4):1390-1. PubMed ID: 27045003
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
    Shipovskaya AA; Dudanova OP; Kurbatova IV
    Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?
    Lonardo A; Nascimbeni F; Ponz de Leon M
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596428
    [No Abstract]   [Full Text] [Related]  

  • 27. The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Clanton J; Subichin M
    Surg Clin North Am; 2016 Aug; 96(4):703-15. PubMed ID: 27473796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autophagy and nonalcoholic fatty liver disease].
    Li XQ; Wang W; Jia YH; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):632-635. PubMed ID: 27788715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: II. Complexity in pathogenesis of nonalcoholic fatty liver disease].
    Ikejima K
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):15-24. PubMed ID: 27266039
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.
    Rosso C; Mezzabotta L; Gaggini M; Salomone F; Gambino R; Marengo A; Saba F; Vanni E; Younes R; Saponaro C; Buzzigoli E; Caviglia GP; Abate ML; Smedile A; Rizzetto M; Cassader M; Gastaldelli A; Bugianesi E
    Hepatology; 2016 Jan; 63(1):107-16. PubMed ID: 26473614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
    He X; Ji G; Jia W; Li H
    Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.
    Ter Horst KW; Gilijamse PW; Versteeg RI; Ackermans MT; Nederveen AJ; la Fleur SE; Romijn JA; Nieuwdorp M; Zhang D; Samuel VT; Vatner DF; Petersen KF; Shulman GI; Serlie MJ
    Cell Rep; 2017 Jun; 19(10):1997-2004. PubMed ID: 28591572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance.
    Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP
    Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of farnesoid X receptor agonists to treat nonalcoholic fatty liver disease.
    Sanyal AJ
    Dig Dis; 2015; 33(3):426-32. PubMed ID: 26045279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin sensitizers in nonalcoholic steatohepatitis.
    Harrison SA; Schenker S; Cusi K
    Hepatology; 2011 Apr; 53(4):1404-5; author reply 1405. PubMed ID: 21480350
    [No Abstract]   [Full Text] [Related]  

  • 36. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to 'Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'.
    Fukuda T; Hamaguchi M; Fukui M
    Liver Int; 2016 Mar; 36(3):462. PubMed ID: 26442842
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease.
    Song Y; Gao L
    EBioMedicine; 2020 Aug; 58():102888. PubMed ID: 32697967
    [No Abstract]   [Full Text] [Related]  

  • 39. Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease.
    Yang Y; Wang J; Zhang Y; Li J; Sun W
    J Agric Food Chem; 2018 Oct; 66(40):10458-10469. PubMed ID: 30244573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.
    Gutiérrez-Grobe Y; Chávez-Tapia N; Sánchez-Valle V; Gavilanes-Espinar JG; Ponciano-Rodríguez G; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2012; 11(3):350-5. PubMed ID: 22481454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.